TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1992269
log Bayes Factor = <0.0001
Chromosome 18   position 1,872,317  (GRCh37) Explore rs1992269 on Ensembl!
Variant rs1992269 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M43.16 Spondylolisthesis (Lumbar region)
0.049 0.951 0.000
K60.3 Anal fistula
0.042 0.958 0.000
M43.1 Spondylolisthesis
0.039 0.961 0.000
M43.17 Spondylolisthesis (Lumbosacral region)
0.034 0.966 0.000
K60.2 Anal fissure, unspecified
0.034 0.966 0.000
K60 Fissure and fistula of anal and rectal regions
0.033 0.967 0.000
I10 Essential (primary) hypertension
0.029 0.971 0.000
M43.19 Spondylolisthesis (Site unspecified)
0.029 0.971 0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.028 0.972 0.000
M43.15 Spondylolisthesis (Thoracolumbar region)
0.028 0.972 0.000
M43.14 Spondylolisthesis (Thoracic region)
0.028 0.972 0.000
M43.13 Spondylolisthesis (Cervicothoracic region)
0.028 0.972 0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.028 0.972 0.000
M43.10 Spondylolisthesis (Multiple sites in spine)
0.028 0.972 0.000
M43.12 Spondylolisthesis (Cervical region)
0.028 0.972 0.000
K60.0 Acute anal fissure
0.025 0.975 0.000
Z35.5 Supervision of elderly primigravida
0.000 0.976 0.024
K60.4 Rectal fistula
0.022 0.978 0.000
M43 Other deforming dorsopathies
0.022 0.978 0.000
K60.5 Anorectal fistula
0.021 0.979 0.000
K60.1 Chronic anal fissure
0.019 0.981 0.000
Z35 Supervision of high-risk pregnancy
0.000 0.982 0.018
Z35.0 Supervision of pregnancy with history of infertility
0.000 0.983 0.017
M43.6 Torticollis
0.017 0.983 0.000
M43.9 Deforming dorsopathy, unspecified
0.016 0.984 0.000
M43.8 Other specified deforming dorsopathies
0.016 0.984 0.000
M43.5 Other recurrent vertebral subluxation
0.016 0.984 0.000
M43.4 Other recurrent atlantoaxial subluxation
0.016 0.984 0.000
M43.3 Recurrent atlantoaxial subluxation with myelopathy
0.016 0.984 0.000
M43.2 Other fusion of spine
0.016 0.984 0.000
I10-I15 Hypertensive diseases
0.016 0.984 0.000
Y57.9 Drug or medicament, unspecified
0.015 0.985 0.000
M43.0 Spondylolysis
0.015 0.985 0.000
Z35.8 Supervision of other high-risk pregnancies
0.000 0.985 0.015
Y57 Other and unspecified drugs and medicaments
0.015 0.985 0.000
Y57.5 X-ray contrast media
0.015 0.985 0.000
I11 Hypertensive heart disease
0.015 0.985 0.000
I11.0 Hypertensive heart disease with (congestive) heart failure
0.014 0.986 0.000
R14 Flatulence and related conditions
0.000 0.986 0.014
Z35.4 Supervision of pregnancy with grand multiparity
0.000 0.987 0.013
M43.62 Torticollis-Cervical
0.013 0.987 0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history
0.000 0.987 0.013
Z35.7 Supervision of high-risk pregnancy due to social problems
0.000 0.987 0.013
Z35.6 Supervision of very young primigravida
0.000 0.987 0.013
Z35.3 Supervision of pregnancy with history of insufficient antenatal care
0.000 0.987 0.013
Y57.8 Other drugs and medicaments
0.013 0.987 0.000
M43.69 Torticollis-Site unspe
0.012 0.988 0.000
M43.68 Torticollis-Sacral/sacrococ
0.012 0.988 0.000
M43.67 Torticollis-Lumbosacral
0.012 0.988 0.000
M43.66 Torticollis-Lumbar
0.012 0.988 0.000
M43.65 Torticollis-Thoracolumbar
0.012 0.988 0.000
M43.64 Torticollis-Thoracic
0.012 0.988 0.000
M43.63 Torticollis-Cervicothoracic
0.012 0.988 0.000
M43.61 Torticollis-Occipit-atl-axl
0.012 0.988 0.000
M43.60 Torticollis-Mult site
0.012 0.988 0.000
M43.06 Spondylolysis (Lumbar region)
0.012 0.988 0.000
Z35.9 Supervision of high-risk pregnancy, unspecified
0.000 0.988 0.012
I11.9 Hypertensive heart disease without (congestive) heart failure
0.012 0.988 0.000
I15 Secondary hypertension
0.012 0.988 0.000
M43.29 Other fusion of spine (Site unspecified)
0.011 0.988 0.000
M43.28 Other fusion of spine (Sacral and sacrococcygeal region)
0.011 0.988 0.000
M43.27 Other fusion of spine (Lumbosacral region)
0.011 0.988 0.000
M43.26 Other fusion of spine (Lumbar region)
0.011 0.988 0.000
M43.25 Other fusion of spine (Thoracolumbar region)
0.011 0.988 0.000
M43.24 Other fusion of spine (Thoracic region)
0.011 0.988 0.000
M43.23 Other fusion of spine (Cervicothoracic region)
0.011 0.988 0.000
M43.22 Other fusion of spine (Cervical region)
0.011 0.988 0.000
M43.21 Other fusion of spine (Occipito-atlanto-axial region)
0.011 0.988 0.000
M43.20 Other fusion of spine (Multiple sites in spine)
0.011 0.988 0.000
M43.39 Recurrent atlantoaxial subluxation with myelopathy (Site unspecified)
0.011 0.988 0.000
M43.38 Recurrent atlantoaxial subluxation with myelopathy (Sacral and sacrococcygeal region)
0.011 0.988 0.000
M43.37 Recurrent atlantoaxial subluxation with myelopathy (Lumbosacral region)
0.011 0.988 0.000
M43.36 Recurrent atlantoaxial subluxation with myelopathy (Lumbar region)
0.011 0.988 0.000
M43.35 Recurrent atlantoaxial subluxation with myelopathy (Thoracolumbar region)
0.011 0.988 0.000
M43.34 Recurrent atlantoaxial subluxation with myelopathy (Thoracic region)
0.011 0.988 0.000
M43.33 Recurrent atlantoaxial subluxation with myelopathy (Cervicothoracic region)
0.011 0.988 0.000
M43.32 Recurrent atlantoaxial subluxation with myelopathy (Cervical region)
0.011 0.988 0.000
M43.31 Recurrent atlantoaxial subluxation with myelopathy (Occipito-atlanto-axial region)
0.011 0.988 0.000
M43.30 Recurrent atlantoaxial subluxation with myelopathy (Multiple sites in spine)
0.011 0.988 0.000
M43.49 Other recurrent atlantoaxial subluxation-Site unspe
0.011 0.988 0.000
M43.48 Other recurrent atlantoaxial subluxation-Sacral/sacrococ
0.011 0.988 0.000
M43.47 Other recurrent atlantoaxial subluxation-Lumbosacral
0.011 0.988 0.000
M43.46 Other recurrent atlantoaxial subluxation-Lumbar
0.011 0.988 0.000
M43.45 Other recurrent atlantoaxial subluxation-Thoracolumbar
0.011 0.988 0.000
M43.44 Other recurrent atlantoaxial subluxation-Thoracic
0.011 0.988 0.000
M43.43 Other recurrent atlantoaxial subluxation-Cervicothoracic
0.011 0.988 0.000
M43.42 Other recurrent atlantoaxial subluxation-Cervical
0.011 0.988 0.000
M43.41 Other recurrent atlantoaxial subluxation-Occipit-atl-axl
0.011 0.988 0.000
M43.40 Other recurrent atlantoaxial subluxation-Mult site
0.011 0.988 0.000
M43.59 Other recurrent vertebral subluxation (Site unspecified)
0.011 0.988 0.000
M43.58 Other recurrent vertebral subluxation (Sacral and sacrococcygeal region)
0.011 0.988 0.000
M43.57 Other recurrent vertebral subluxation (Lumbosacral region)
0.011 0.988 0.000
M43.56 Other recurrent vertebral subluxation (Lumbar region)
0.011 0.988 0.000
M43.55 Other recurrent vertebral subluxation (Thoracolumbar region)
0.011 0.988 0.000
M43.54 Other recurrent vertebral subluxation (Thoracic region)
0.011 0.988 0.000
M43.53 Other recurrent vertebral subluxation (Cervicothoracic region)
0.011 0.988 0.000
M43.52 Other recurrent vertebral subluxation (Cervical region)
0.011 0.988 0.000
M43.51 Other recurrent vertebral subluxation-Occipit-atl-axl
0.011 0.988 0.000
M43.50 Other recurrent vertebral subluxation (Multiple sites in spine)
0.011 0.988 0.000
M43.89 Other specified deforming dorsopathies (Site unspecified)
0.011 0.988 0.000
M43.88 Other specified deforming dorsopathies (Sacral and sacrococcygeal region)
0.011 0.988 0.000
M43.87 Other specified deforming dorsopathies (Lumbosacral region)
0.011 0.988 0.000
M43.86 Other specified deforming dorsopathies (Lumbar region)
0.011 0.988 0.000
M43.85 Other specified deforming dorsopathies (Thoracolumbar region)
0.011 0.988 0.000
M43.84 Other specified deforming dorsopathies (Thoracic region)
0.011 0.988 0.000
M43.83 Other specified deforming dorsopathies (Cervicothoracic region)
0.011 0.988 0.000
M43.82 Other specified deforming dorsopathies (Cervical region)
0.011 0.988 0.000
M43.81 Other specified deforming dorsopathies (Occipito-atlanto-axial region)
0.011 0.988 0.000
M43.80 Other specified deforming dorsopathies (Multiple sites in spine)
0.011 0.988 0.000
M43.99 Deforming dorsopathy, unspecified (Site unspecified)
0.011 0.988 0.000
M43.98 Deforming dorsopathy, unspecified (Sacral and sacrococcygeal region)
0.011 0.988 0.000
M43.97 Deforming dorsopathy, unspecified (Lumbosacral region)
0.011 0.988 0.000
M43.96 Deforming dorsopathy, unspecified (Lumbar region)
0.011 0.988 0.000
M43.95 Deforming dorsopathy, unspecified (Thoracolumbar region)
0.011 0.988 0.000
M43.94 Deforming dorsopathy, unspecified (Thoracic region)
0.011 0.988 0.000
M43.93 Deforming dorsopathy, unspecified (Cervicothoracic region)
0.011 0.988 0.000
M43.92 Deforming dorsopathy, unspecified (Cervical region)
0.011 0.988 0.000
M43.91 Deforming dorsopathy, unspecified (Occipito-atlanto-axial region)
0.011 0.988 0.000
M43.90 Deforming dorsopathy, unspecified (Multiple sites in spine)
0.011 0.988 0.000
I13 Hypertensive heart and renal disease
0.011 0.989 0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)
0.011 0.989 0.000
M43.07 Spondylolysis (Lumbosacral region)
0.011 0.989 0.000
M43.05 Spondylolysis (Thoracolumbar region)
0.011 0.989 0.000
M43.04 Spondylolysis (Thoracic region)
0.011 0.989 0.000
M43.03 Spondylolysis (Cervicothoracic region)
0.011 0.989 0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)
0.011 0.989 0.000
M43.00 Spondylolysis (Multiple sites in spine)
0.011 0.989 0.000
Y57.6 Other diagnostic agents
0.011 0.989 0.000
Y57.7 Vitamins, not elsewhere classified
0.011 0.989 0.000
Y57.4 Pharmaceutical excipients
0.011 0.989 0.000
Y57.3 Alcohol deterrents
0.011 0.989 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.011 0.989 0.000
Y57.1 Lipotropic drugs
0.011 0.989 0.000
Y57.0 Appetite depressants [anorectics]
0.011 0.989 0.000
M43.09 Spondylolysis (Site unspecified)
0.010 0.989 0.000
M43.02 Spondylolysis (Cervical region)
0.010 0.990 0.000
I15.9 Seconday hypertension, unspecified
0.009 0.991 0.000
Z35.1 Supervision of pregnancy with history of abortive outcome
0.000 0.991 0.009
W19.4 Street and highway
0.009 0.991 0.000
I15.8 Other secondary hypertension
0.009 0.991 0.000
I15.2 Hypertension secondary to endocrine disorders
0.009 0.991 0.000
I15.0 Renovascular hypertension
0.009 0.991 0.000
I13.9 Hypertensive heart and renal disease, unspecified
0.008 0.992 0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.008 0.992 0.000
I13.1 Hypertensive heart and renal disease with renal failure
0.008 0.992 0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.008 0.992 0.000
I15.1 Hypertension secondary to other renal disorders
0.008 0.992 0.000
W19.2 School, other institution and public administrative area
0.008 0.992 0.000
M40-M43 Deforming dorsopathies
0.008 0.992 0.000
W19 Unspecified fall
0.007 0.993 0.000
W19.1 Residential institution
0.007 0.993 0.000
H72.0 Central perforation of tympanic membrane
0.000 0.993 0.007
H72.9 Perforation of tympanic membrane, unspecified
0.000 0.994 0.006
Y40.3 Macrolides
0.006 0.994 0.000
W19.6 Industrial and construction area
0.006 0.994 0.000
K25.3 Acute without haemorrhage or perforation
0.006 0.994 0.000
Y52 Agents primarily affecting the cardiovascular system
0.006 0.994 0.000
Y40 Systemic antibiotics
0.006 0.994 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.006 0.994 0.000
H72 Perforation of tympanic membrane
0.000 0.994 0.006
M42 Spinal osteochondrosis
0.006 0.994 0.000
R47.0 Dysphasia and aphasia
0.000 0.994 0.006
M41 Scoliosis
0.006 0.994 0.000
I12 Hypertensive renal disease
0.006 0.994 0.000
W19.8 Other specified place
0.005 0.994 0.000
W19.5 Trade and service area
0.005 0.994 0.000
W19.0 Home
0.005 0.994 0.000
W19.7 Farm
0.005 0.994 0.000
Y40.0 Penicillins
0.005 0.995 0.000
Y52.1 Calcium-channel blockers
0.005 0.995 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue
0.000 0.995 0.005
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.005 0.995 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.995 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.995 0.000
M40 Kyphosis and lordosis
0.005 0.995 0.000
W08.0 Home
0.005 0.995 0.000
W19.3 Sports and athletics area
0.005 0.995 0.000
Y52.7 Peripheral vasodilators
0.005 0.995 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
M41.5 Other secondary scoliosis
0.005 0.995 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.005 0.995 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
H72.1 Attic perforation of tympanic membrane
0.000 0.995 0.005
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
H72.8 Other perforations of tympanic membrane
0.000 0.995 0.005
Y40.6 Rifamycins
0.005 0.995 0.000
Y40.7 Antifungal antibiotics, systemically used
0.004 0.995 0.000
I24.9 Acute ischaemic heart disease, unspecified
0.005 0.995 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.004 0.995 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.004 0.995 0.000
Y40.4 Tetracyclines
0.004 0.995 0.000
Y40.2 Chloramphenicol group
0.004 0.995 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.004 0.995 0.000
Y59 Other and unspecified vaccines and biological substances
0.004 0.996 0.000
Y58 Bacterial vaccines
0.004 0.996 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.004 0.996 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.004 0.996 0.000
M41.8 Other forms of scoliosis
0.004 0.996 0.000
M42.9 Spinal osteochondrosis, unspecified
0.004 0.996 0.000
M42.1 Adult osteochondrosis of spine
0.004 0.996 0.000
M42.0 Juvenile osteochondrosis of spine
0.004 0.996 0.000
M41.4 Neuromuscular scoliosis
0.004 0.996 0.000
M41.3 Thoracogenic scoliosis
0.004 0.996 0.000
M41.2 Other idiopathic scoliosis
0.004 0.996 0.000
M41.1 Juvenile idiopathic scoliosis
0.004 0.996 0.000
M41.0 Infantile idiopathic scoliosis
0.004 0.996 0.000
Y44 Agents primarily affecting blood constituents
0.004 0.996 0.000
Y40.5 Aminoglycosides
0.004 0.996 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.004 0.996 0.000
H72.2 Other marginal perforations of tympanic membrane
0.000 0.996 0.004
W19.09 Unspecified fall; Home; During unspecified activity
0.004 0.996 0.000
W19.08 Unspecified fall; Home; While engaged in other specified activities
0.004 0.996 0.000
W19.59 Unspecified fall; Trade and service area; During unspecified activity
0.004 0.996 0.000
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity
0.004 0.996 0.000
M41.56 Other secondary scoliosis (Lumbar region)
0.004 0.996 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.004 0.996 0.000
Y40.9 Systemic antibiotic, unspecified
0.004 0.996 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.004 0.996 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.004 0.996 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
W08 Fall involving other furniture
0.004 0.996 0.000
J42 Unspecified chronic bronchitis
0.004 0.996 0.000
Y56.9 Topical agent, unspecified
0.004 0.996 0.000
Y56.8 Other topical agents
0.004 0.996 0.000
Y56.7 Dental drugs, topically applied
0.004 0.996 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.004 0.996 0.000
Y56.5 Ophthalmological drugs and preparations
0.004 0.996 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.004 0.996 0.000
Y56.3 Emollients, demulcents and protectants
0.004 0.996 0.000
Y56.2 Local astringents and local detergents
0.004 0.996 0.000
Y56.1 Antipruritics
0.004 0.996 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.996 0.000
M40.5 Lordosis, unspecified
0.004 0.996 0.000
M40.4 Other lordosis
0.004 0.996 0.000
M40.3 Flatback syndrome
0.004 0.996 0.000
M40.1 Other secondary kyphosis
0.004 0.996 0.000
M40.0 Postural kyphosis
0.004 0.996 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.004 0.996 0.000
Y40.8 Other systemic antibiotics
0.004 0.996 0.000
Y45.1 Salicylates
0.004 0.996 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.004 0.996 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
Y53.7 Emetics
0.004 0.996 0.000
Y53.6 Antidiarrhoeal drugs
0.004 0.996 0.000
Y53.5 Digestants
0.004 0.996 0.000
Y53.3 Saline and osmotic laxatives
0.004 0.996 0.000
Y53.2 Stimulant laxatives
0.004 0.996 0.000
Y53.0 Histamine H2-receptor antagonists
0.004 0.996 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.004 0.996 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.004 0.996 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.004 0.996 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.004 0.996 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.004 0.996 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.004 0.996 0.000
Y51.0 Anticholinesterase agents
0.004 0.996 0.000
M41.59 Other secondary scoliosis (Site unspecified)
0.004 0.996 0.000
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M41.57 Other secondary scoliosis (Lumbosacral region)
0.004 0.996 0.000
M41.55 Other secondary scoliosis (Thoracolumbar region)
0.004 0.996 0.000
M41.54 Other secondary scoliosis (Thoracic region)
0.004 0.996 0.000
M41.53 Other secondary scoliosis (Cervicothoracic region)
0.004 0.996 0.000
M41.52 Other secondary scoliosis (Cervical region)
0.004 0.996 0.000
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)
0.004 0.996 0.000
M41.50 Other secondary scoliosis (Multiple sites in spine)
0.004 0.996 0.000
Z39.0 Care and examination immediately after delivery
0.000 0.996 0.004
Y41 Other systemic anti-infectives and antiparasitics
0.004 0.996 0.000
Y44.5 Thrombolytic drugs
0.004 0.996 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.996 0.000
W08.9 Unspecified place
0.004 0.996 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.003 0.996 0.000
N85.8 Other specified noninflammatory disorders of uterus
0.000 0.996 0.004
Y45.5 4-Aminophenol derivatives
0.004 0.996 0.000
C45.0 Mesothelioma of pleura
0.000 0.996 0.004
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
0.000 0.996 0.004
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.003 0.996 0.000
Z82.3 Family history of stroke
0.004 0.996 0.000
Y45.0 Opioids and related analgesics
0.004 0.996 0.000
M41.86 Other forms of scoliosis (Lumbar region)
0.003 0.996 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.003 0.996 0.000
Y50.9 Central nervous system stimulant, unspecified
0.003 0.997 0.000
Y50.8 Other central nervous system stimulants
0.003 0.997 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.003 0.997 0.000
Y50.1 Opioid receptor antagonists
0.003 0.997 0.000
Y50.0 Analeptics
0.003 0.997 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.003 0.997 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.003 0.997 0.000
Y55.5 Anticommon cold drugs
0.003 0.997 0.000
Y55.4 Expectorants
0.003 0.997 0.000
Y55.3 Antitussives
0.003 0.997 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.003 0.997 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.003 0.997 0.000
Y55.0 Oxytocic drugs
0.003 0.997 0.000
Y58.9 Other and unspecified bacterial vaccines
0.003 0.997 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.003 0.997 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.003 0.997 0.000
Y58.5 Diphtheria vaccine
0.003 0.997 0.000
Y58.4 Tetanus vaccine
0.003 0.997 0.000
Y58.3 Plague vaccine
0.003 0.997 0.000
Y58.2 Cholera vaccine
0.003 0.997 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.003 0.997 0.000
Y58.0 BCG vaccine
0.003 0.997 0.000
Y59.9 Vaccine or biological substance, unspecified
0.003 0.997 0.000
Y59.8 Other specified vaccines and biological substances
0.003 0.997 0.000
Y59.3 Immunoglobulin
0.003 0.997 0.000
Y59.2 Protozoal vaccines
0.003 0.997 0.000
Y59.1 Rickettsial vaccines
0.003 0.997 0.000
Y59.0 Viral vaccines
0.003 0.997 0.000
M41.89 Other forms of scoliosis (Site unspecified)
0.003 0.997 0.000
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M41.87 Other forms of scoliosis (Lumbosacral region)
0.003 0.997 0.000
M41.85 Other forms of scoliosis (Thoracolumbar region)
0.003 0.997 0.000
M41.84 Other forms of scoliosis (Thoracic region)
0.003 0.997 0.000
M41.83 Other forms of scoliosis (Cervicothoracic region)
0.003 0.997 0.000
M41.82 Other forms of scoliosis (Cervical region)
0.003 0.997 0.000
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M41.80 Other forms of scoliosis (Multiple sites in spine)
0.003 0.997 0.000
M42.09 Juvenile osteochondrosis of spine (Site unspecified)
0.003 0.997 0.000
M42.08 Juvenile osteochondrosis of spine (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M42.07 Juvenile osteochondrosis of spine (Lumbosacral region)
0.003 0.997 0.000
M42.06 Juvenile osteochondrosis of spine (Lumbar region)
0.003 0.997 0.000
M42.05 Juvenile osteochondrosis of spine (Thoracolumbar region)
0.003 0.997 0.000
M42.04 Juvenile osteochondrosis of spine (Thoracic region)
0.003 0.997 0.000
M42.03 Juvenile osteochondrosis of spine (Cervicothoracic region)
0.003 0.997 0.000
M42.02 Juvenile osteochondrosis of spine (Cervical region)
0.003 0.997 0.000
M42.01 Juvenile osteochondrosis of spine (Occipito-atlanto-axial region)
0.003 0.997 0.000
M42.00 Juvenile osteochondrosis of spine (Multiple sites in spine)
0.003 0.997 0.000
M42.19 Adult osteochondrosis of spine (Site unspecified)
0.003 0.997 0.000
M42.18 Adult osteochondrosis of spine (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M42.17 Adult osteochondrosis of spine (Lumbosacral region)
0.003 0.997 0.000
M42.16 Adult osteochondrosis of spine (Lumbar region)
0.003 0.997 0.000
M42.15 Adult osteochondrosis of spine (Thoracolumbar region)
0.003 0.997 0.000
M42.14 Adult osteochondrosis of spine (Thoracic region)
0.003 0.997 0.000
M42.13 Adult osteochondrosis of spine (Cervicothoracic region)
0.003 0.997 0.000
M42.12 Adult osteochondrosis of spine (Cervical region)
0.003 0.997 0.000
M42.11 Adult osteochondrosis of spine (Occipito-atlanto-axial region)
0.003 0.997 0.000
M42.10 Adult osteochondrosis of spine (Multiple sites in spine)
0.003 0.997 0.000
M42.99 Spinal osteochondrosis, unspecified (Site unspecified)
0.003 0.997 0.000
M42.98 Spinal osteochondrosis, unspecified (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M42.97 Spinal osteochondrosis, unspecified (Lumbosacral region)
0.003 0.997 0.000
M42.96 Spinal osteochondrosis, unspecified (Lumbar region)
0.003 0.997 0.000
M42.95 Spinal osteochondrosis, unspecified (Thoracolumbar region)
0.003 0.997 0.000
M42.94 Spinal osteochondrosis, unspecified (Thoracic region)
0.003 0.997 0.000
M42.93 Spinal osteochondrosis, unspecified (Cervicothoracic region)
0.003 0.997 0.000
M42.92 Spinal osteochondrosis, unspecified (Cervical region)
0.003 0.997 0.000
M42.91 Spinal osteochondrosis, unspecified (Occipito-atlanto-axial region)
0.003 0.997 0.000
M42.90 Spinal osteochondrosis, unspecified (Multiple sites in spine)
0.003 0.997 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.003 0.997 0.000
I12.9 Hypertensive renal disease without renal failure
0.003 0.997 0.000
M41.9 Scoliosis, unspecified
0.003 0.997 0.000
M41.09 Infantile idiopathic scoliosis (Site unspecified)
0.003 0.997 0.000
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)
0.003 0.997 0.000
M41.06 Infantile idiopathic scoliosis (Lumbar region)
0.003 0.997 0.000
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)
0.003 0.997 0.000
M41.04 Infantile idiopathic scoliosis (Thoracic region)
0.003 0.997 0.000
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)
0.003 0.997 0.000
M41.02 Infantile idiopathic scoliosis (Cervical region)
0.003 0.997 0.000
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)
0.003 0.997 0.000
M41.19 Juvenile idiopathic scoliosis (Site unspecified)
0.003 0.997 0.000
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)
0.003 0.997 0.000
M41.16 Juvenile idiopathic scoliosis (Lumbar region)
0.003 0.997 0.000
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)
0.003 0.997 0.000
M41.14 Juvenile idiopathic scoliosis (Thoracic region)
0.003 0.997 0.000
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)
0.003 0.997 0.000
M41.12 Juvenile idiopathic scoliosis (Cervical region)
0.003 0.997 0.000
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)
0.003 0.997 0.000
M41.29 Other idiopathic scoliosis (Site unspecified)
0.003 0.997 0.000
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M41.27 Other idiopathic scoliosis (Lumbosacral region)
0.003 0.997 0.000
M41.26 Other idiopathic scoliosis (Lumbar region)
0.003 0.997 0.000
M41.25 Other idiopathic scoliosis (Thoracolumbar region)
0.003 0.997 0.000
M41.24 Other idiopathic scoliosis (Thoracic region)
0.003 0.997 0.000
M41.23 Other idiopathic scoliosis (Cervicothoracic region)
0.003 0.997 0.000
M41.22 Other idiopathic scoliosis (Cervical region)
0.003 0.997 0.000
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M41.20 Other idiopathic scoliosis (Multiple sites in spine)
0.003 0.997 0.000
M41.39 Thoracogenic scoliosis-Site unspe
0.003 0.997 0.000
M41.38 Thoracogenic scoliosis-Sacral/sacrococ
0.003 0.997 0.000
M41.37 Thoracogenic scoliosis-Lumbosacral
0.003 0.997 0.000
M41.36 Thoracogenic scoliosis-Lumbar
0.003 0.997 0.000
M41.35 Thoracogenic scoliosis (Thoracolumbar region)
0.003 0.997 0.000
M41.34 Thoracogenic scoliosis (Thoracic region)
0.003 0.997 0.000
M41.33 Thoracogenic scoliosis (Cervicothoracic region)
0.003 0.997 0.000
M41.32 Thoracogenic scoliosis-Cervical
0.003 0.997 0.000
M41.31 Thoracogenic scoliosis-Occipit-atl-axl
0.003 0.997 0.000
M41.30 Thoracogenic scoliosis (Multiple sites in spine)
0.003 0.997 0.000
M41.49 Neuromuscular scoliosis (Site unspecified)
0.003 0.997 0.000
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M41.47 Neuromuscular scoliosis (Lumbosacral region)
0.003 0.997 0.000
M41.46 Neuromuscular scoliosis (Lumbar region)
0.003 0.997 0.000
M41.45 Neuromuscular scoliosis (Thoracolumbar region)
0.003 0.997 0.000
M41.44 Neuromuscular scoliosis (Thoracic region)
0.003 0.997 0.000
M41.43 Neuromuscular scoliosis (Cervicothoracic region)
0.003 0.997 0.000
M41.42 Neuromuscular scoliosis (Cervical region)
0.003 0.997 0.000
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M41.40 Neuromuscular scoliosis (Multiple sites in spine)
0.003 0.997 0.000
H59.8 Other postprocedural disorders of eye and adnexa
0.003 0.997 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.003 0.997 0.000
Y44.7 Plasma substitutes
0.003 0.997 0.000
Y44.6 Natural blood and blood products
0.003 0.997 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.003 0.997 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.003 0.997 0.000
Y48 Anaesthetics and therapeutic gases
0.003 0.997 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.003 0.997 0.000
Y45.4 Antirheumatics
0.003 0.997 0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
0.003 0.997 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.003 0.997 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.003 0.997 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.003 0.997 0.000
Y47.4 Bromine compounds
0.003 0.997 0.000
Y47.3 Paraldehyde
0.003 0.997 0.000
Y47.2 Chloral derivatives
0.003 0.997 0.000
Y47.0 Barbiturates, not elsewhere classified
0.003 0.997 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.003 0.997 0.000
Y46.8 Antispasticity drugs
0.003 0.997 0.000
Y46.7 Anti-Parkinsonism drugs
0.003 0.997 0.000
Y46.5 Valproic acid
0.003 0.997 0.000
Y46.3 Deoxybarbiturates
0.003 0.997 0.000
Y46.1 Oxazolidinediones
0.003 0.997 0.000
Y46.0 Succinimides
0.003 0.997 0.000
Y54.5 Other diuretics
0.003 0.997 0.000
W08.8 Other specified place
0.003 0.997 0.000
W08.7 Farm
0.003 0.997 0.000
W08.6 Industrial and construction area
0.003 0.997 0.000
W08.5 Trade and service area
0.003 0.997 0.000
W08.4 Street and highway
0.003 0.997 0.000
W08.3 Sports and athletics area
0.003 0.997 0.000
W08.2 School, other institution and public administrative area
0.003 0.997 0.000
W08.1 Residential institution
0.003 0.997 0.000
Y49.9 Psychotropic drug, unspecified
0.003 0.997 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
Y49.7 Psychostimulants with abuse potential
0.003 0.997 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.003 0.997 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.003 0.997 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.003 0.997 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.003 0.997 0.000
Y60.0 During surgical operation
0.003 0.997 0.000
M81.98 Osteoporosis, unspecified (Other)
0.003 0.997 0.000
M40.2 Other and unspecified kyphosis
0.003 0.997 0.000
Y46.6 Other and unspecified antiepileptics
0.003 0.997 0.000
Y46.4 Iminostilbenes
0.003 0.997 0.000
Y53.4 Other laxatives
0.003 0.997 0.000
Y60.8 During other surgical and medical care
0.003 0.997 0.000
M40.09 Postural kyphosis (Site unspecified)
0.003 0.997 0.000
M40.08 Postural kyphosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M40.07 Postural kyphosis (Lumbosacral region)
0.003 0.997 0.000
M40.06 Postural kyphosis (Lumbar region)
0.003 0.997 0.000
M40.05 Postural kyphosis (Thoracolumbar region)
0.003 0.997 0.000
M40.04 Postural kyphosis (Thoracic region)
0.003 0.997 0.000
M40.03 Postural kyphosis (Cervicothoracic region)
0.003 0.997 0.000
M40.02 Postural kyphosis (Cervical region)
0.003 0.997 0.000
M40.01 Postural kyphosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M40.00 Postural kyphosis (Multiple sites in spine)
0.003 0.997 0.000
M40.19 Other secondary kyphosis (Site unspecified)
0.003 0.997 0.000
M40.18 Other secondary kyphosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M40.17 Other secondary kyphosis (Lumbosacral region)
0.003 0.997 0.000
M40.16 Other secondary kyphosis (Lumbar region)
0.003 0.997 0.000
M40.15 Other secondary kyphosis (Thoracolumbar region)
0.003 0.997 0.000
M40.14 Other secondary kyphosis (Thoracic region)
0.003 0.997 0.000
M40.13 Other secondary kyphosis (Cervicothoracic region)
0.003 0.997 0.000
M40.12 Other secondary kyphosis (Cervical region)
0.003 0.997 0.000
M40.11 Other secondary kyphosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M40.10 Other secondary kyphosis (Multiple sites in spine)
0.003 0.997 0.000
M40.39 Flatback syndrome (Site unspecified)
0.003 0.997 0.000
M40.38 Flatback syndrome (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M40.37 Flatback syndrome (Lumbosacral region)
0.003 0.997 0.000
M40.36 Flatback syndrome (Lumbar region)
0.003 0.997 0.000
M40.35 Flatback syndrome (Thoracolumbar region)
0.003 0.997 0.000
M40.34 Flatback syndrome (Thoracic region)
0.003 0.997 0.000
M40.33 Flatback syndrome (Cervicothoracic region)
0.003 0.997 0.000
M40.32 Flatback syndrome (Cervical region)
0.003 0.997 0.000
M40.31 Flatback syndrome (Occipito-atlanto-axial region)
0.003 0.997 0.000
M40.30 Flatback syndrome (Multiple sites in spine)
0.003 0.997 0.000
M40.49 Other lordosis (Site unspecified)
0.003 0.997 0.000
M40.48 Other lordosis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M40.47 Other lordosis (Lumbosacral region)
0.003 0.997 0.000
M40.46 Other lordosis (Lumbar region)
0.003 0.997 0.000
M40.45 Other lordosis (Thoracolumbar region)
0.003 0.997 0.000
M40.44 Other lordosis (Thoracic region)
0.003 0.997 0.000
M40.43 Other lordosis (Cervicothoracic region)
0.003 0.997 0.000
M40.42 Other lordosis (Cervical region)
0.003 0.997 0.000
M40.41 Other lordosis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M40.40 Other lordosis (Multiple sites in spine)
0.003 0.997 0.000
M40.59 Lordosis, unspecified (Site unspecified)
0.003 0.997 0.000
M40.58 Lordosis, unspecified (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M40.57 Lordosis, unspecified (Lumbosacral region)
0.003 0.997 0.000
M40.56 Lordosis, unspecified (Lumbar region)
0.003 0.997 0.000
M40.55 Lordosis, unspecified (Thoracolumbar region)
0.003 0.997 0.000
M40.54 Lordosis, unspecified (Thoracic region)
0.003 0.997 0.000
M40.53 Lordosis, unspecified (Cervicothoracic region)
0.003 0.997 0.000
M40.52 Lordosis, unspecified (Cervical region)
0.003 0.997 0.000
M40.51 Lordosis, unspecified (Occipito-atlanto-axial region)
0.003 0.997 0.000
M40.50 Lordosis, unspecified (Multiple sites in spine)
0.003 0.997 0.000
Y46.2 Hydantoin derivatives
0.003 0.997 0.000
K62.7 Radiation proctitis
0.003 0.997 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.